Watch the full video
Events
On May 25th, Astellas announces its intended decision to transfer its manufacturing plant and business based in Meppel, the Netherlands to Delpharm. The definitive agreement will be executed after completing works council consultation and local legal and regulatory requirements.
On February 17th, Delpharm finalized the acquisition of Carelide manufacturing site specialized in infusion bags, located in France.
A leading CDMO
Drug developer and Contract manufacturer. With its plants network, Delpharm is in the Top 5 CDMOs Worldwide.
Dosage forms
Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.
Development & Regulation
A team of experts to support new pharmaceutical products.
100
Management ownership 100%
1
Turnover billion €
5
World Top 5
6000
Headcount
Serialization
Major on going project for Delpharm since 2015, all Delpharm plants already shipping serialized products.Read more...
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.Read more...
Soft gel capsules
Delpharm now offers the manufacturing and packaging of soft gel capsules in Evreux plant and high potent soft gel capsules in Poznań.Freeze-drying
New dosage form now available at Delpharm plants.Customer references
